Fundraising Fox
Lexeotx
New York City, US · Founded 2018 · 101 employees on LinkedIn · 2 known investors
Find your way into Lexeotx
Sign up to see every warm intro you have to Lexeotx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lexeotx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.
Founders & leadership
Lexeotx was founded in 2018 by Ronald Crystal, MD.
Investors · 2
Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lexeotx do?
- Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.
- Who founded Lexeotx?
- Lexeotx was founded by Ronald Crystal, MD in 2018.
- Who are Lexeotx's investors?
- Lexeotx's investors include Longitude Capital, OrbiMed.
- Where is Lexeotx headquartered?
- Lexeotx is headquartered in New York City, US.